Cargando…

Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess

Clostridioides (formerly Clostridium) difficile infection is a common and costly healthcare-associated infection. Extraintestinal C. difficile infection is rarely encountered, especially in isolation. We present a unique case of abdominal wall abscess presenting six months following gastrointestinal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chinnappan, Justine, Hussain, Murtaza, Awuah, Dominic, Ogbon, Ekwevugbe, Bachuwa, Ghassan, McDonald, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SMC Media Srl 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930881/ https://www.ncbi.nlm.nih.gov/pubmed/36819648 http://dx.doi.org/10.12890/2023_003711

Ejemplares similares

Unveiling of Type B Lactic Acidosis From Systemic Lupus Erythematosus-Associated B-cell Lymphoma: A Fatal Oncology Emergency
por: Chirumamilla, Yashitha, et al.
Publicado: (2023)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
por: Finn, Elaine, et al.
Publicado: (2021)

Clostridioides difficile infection (CDI) during the COVID-19 pandemic
por: Spigaglia, Patrizia
Publicado: (2022)

684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
por: Guh, Alice, et al.
Publicado: (2023)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
por: Kullar, Ravina, et al.
Publicado: (2020)

Acute organoaxial gastric volvulus—A dangerous twist
por: Chinnappan, Justine, et al.
Publicado: (2022)

Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection
por: Mileto, Steven J., et al.
Publicado: (2022)

2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
por: Wiese, Maria, et al.
Publicado: (2022)

COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients
por: Spigaglia, Patrizia
Publicado: (2020)

Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales
por: Tydeman, Florence, et al.
Publicado: (2021)

Clostridioides difficile infection (CDI) treatment outcomes and recurrence factor at a pediatric hospital
por: Tran, Martin Tuan, et al.
Publicado: (2022)

Biofilm Formation of Clostridioides difficile, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI
por: Dicks, Leon M. T.
Publicado: (2023)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
por: Viprey, Virginie F, et al.
Publicado: (2022)

Extraintestinal Clostridioides difficile Infections: Epidemiology in a University Hospital in Hungary and Review of the Literature
por: Urbán, Edit, et al.
Publicado: (2020)

Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: A Retrospective Diagnosis
por: Al-Handola, Rami, et al.
Publicado: (2023)

Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI)
por: Manthey, Carolin F., et al.
Publicado: (2019)

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens
por: Venhorst, Jennifer, et al.
Publicado: (2022)

135. Impact of Clostridioides difficile Toxin Confirmation on Subsequent C. difficile Treatment in a Rural Health System (IT-CDI)
por: Crawford, Jacquelyn, et al.
Publicado: (2023)

Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy
por: Palanisamy, Nageshwari, et al.
Publicado: (2023)

Atypical Splenic Abscesses Due to Clostridioides difficile
por: Komeno, Yukiko, et al.
Publicado: (2022)

2382. Recurrent Clostridioides difficile Infection (CDI) Worsens Anxiety-Related Patient-Reported Quality of Life
por: Garey, Kevin W, et al.
Publicado: (2019)

2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime
por: Rathod, Shardul, et al.
Publicado: (2019)

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)
por: Khanna, Sahil, et al.
Publicado: (2022)

710. Burden of Clostridioides difficile Infection (CDI) in Flint, Michigan (MI): Association of Race and Gender with Mortality
por: Younas, Mariam, et al.
Publicado: (2023)

Methotrexate-Induced Lymphoproliferative Disorder Complicating Into Spontaneous Tumor Lysis Syndrome and Disseminated Intravascular Coagulation
por: Parajuli, Abinash, et al.
Publicado: (2023)

1930. Quality of Life among Patients with Community-onset Clostridioides difficile Infection (CDI) without Subsequent Hospitalization
por: Schmidt, Mark A, et al.
Publicado: (2023)

Constipation in transverse myelitis
por: Chinnappan, Justine, et al.
Publicado: (2023)

Fungating Breast Cancer with Metastasis in a Developed Country: A Caveat to Our Strategy
por: Chinnappan, Justine, et al.
Publicado: (2023)

394. Impact of Misdiagnosis of Clostridioides difficile Infection (CDI) by Standard-of-care Specimen Collection and Testing on Estimates of Hospitalized CDI Incidence Among Adults in Louisville, Kentucky, 2019-2020
por: Ramirez, Julio A, et al.
Publicado: (2022)

741. Antifungal Resistant Candida glabrata Are Most Commonly Colonized in Clostridioides difficile Infection (CDI) Patient Guts in Texas
por: Begum, Khurshida, et al.
Publicado: (2020)

Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI?
por: Popa, Daniel, et al.
Publicado: (2021)

Reductions in inpatient fluoroquinolone use and postdischarge Clostridioides difficile infection (CDI) from a systemwide antimicrobial stewardship intervention
por: Jones, K. Ashley, et al.
Publicado: (2021)

395. Impact of Racial Disparities on Clostridioides difficile Infection (CDI) Outcomes at a Southern California Academic Teaching Hospital
por: Zhou, Anna Y, et al.
Publicado: (2022)

Acute confusional state as a prognostic sign of COVID-19 large-vessel occlusion (LVO)
por: Deliwala, Smit Sunil, et al.
Publicado: (2021)

The Management of Acute Onset Complete Heart Block and Atrial Flutter in a Patient with COVID-19
por: Hussain, Murtaza, et al.
Publicado: (2022)

1498. Assess Risk Factors, Mortality, and Healthcare Utilization Associated with Clostridioides difficile Infection (CDI) in 4 Latin American Countries
por: Yu, Holly, et al.
Publicado: (2019)

Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation
por: Mahgoub, Abdullahi E, et al.
Publicado: (2022)

A Fatal Case of Systemic Calciphylaxis in the Gastrointestinal Tract: A Case Report and Literature Review
por: Chinnappan, Justine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2l1miuboos9dh48olfcpbl3rv